EPRX
Price
$5.85
Change
-$0.15 (-2.50%)
Updated
Oct 3 closing price
Capitalization
294.61M
30 days until earnings call
LEXX
Price
$0.88
Change
-$0.01 (-1.12%)
Updated
Oct 3 closing price
Capitalization
19.53M
23 days until earnings call
Interact to see
Advertisement

EPRX vs LEXX

Header iconEPRX vs LEXX Comparison
Open Charts EPRX vs LEXXBanner chart's image
Eupraxia Pharmaceuticals
Price$5.85
Change-$0.15 (-2.50%)
Volume$47.97K
Capitalization294.61M
Lexaria Bioscience
Price$0.88
Change-$0.01 (-1.12%)
Volume$579.48K
Capitalization19.53M
EPRX vs LEXX Comparison Chart in %
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LEXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EPRX vs. LEXX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPRX is a StrongBuy and LEXX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (EPRX: $5.85 vs. LEXX: $0.88)
Brand notoriety: EPRX and LEXX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPRX: 52% vs. LEXX: 88%
Market capitalization -- EPRX: $294.61M vs. LEXX: $19.53M
EPRX [@Biotechnology] is valued at $294.61M. LEXX’s [@Biotechnology] market capitalization is $19.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPRX’s FA Score shows that 0 FA rating(s) are green whileLEXX’s FA Score has 1 green FA rating(s).

  • EPRX’s FA Score: 0 green, 5 red.
  • LEXX’s FA Score: 1 green, 4 red.
According to our system of comparison, both EPRX and LEXX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPRX’s TA Score shows that 6 TA indicator(s) are bullish while LEXX’s TA Score has 4 bullish TA indicator(s).

  • EPRX’s TA Score: 6 bullish, 4 bearish.
  • LEXX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, EPRX is a better buy in the short-term than LEXX.

Price Growth

EPRX (@Biotechnology) experienced а +1.92% price change this week, while LEXX (@Biotechnology) price change was -16.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

EPRX is expected to report earnings on Nov 05, 2025.

LEXX is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EPRX($295M) has a higher market cap than LEXX($19.5M). EPRX YTD gains are higher at: 84.543 vs. LEXX (-58.152). LEXX has higher annual earnings (EBITDA): -11.31M vs. EPRX (-28.83M). EPRX has more cash in the bank: 19.8M vs. LEXX (4.63M). EPRX has less debt than LEXX: EPRX (35.1K) vs LEXX (117K). LEXX has higher revenues than EPRX: LEXX (616K) vs EPRX (0).
EPRXLEXXEPRX / LEXX
Capitalization295M19.5M1,513%
EBITDA-28.83M-11.31M255%
Gain YTD84.543-58.152-145%
P/E RatioN/AN/A-
Revenue0616K-
Total Cash19.8M4.63M428%
Total Debt35.1K117K30%
FUNDAMENTALS RATINGS
LEXX: Fundamental Ratings
LEXX
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EPRXLEXX
RSI
ODDS (%)
Bearish Trend 4 days ago
64%
Bearish Trend 4 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
61%
Bullish Trend 4 days ago
85%
Momentum
ODDS (%)
Bearish Trend 4 days ago
67%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
43%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
42%
Bearish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 12 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LEXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INDI4.280.03
+0.71%
indie Semiconductor
XYL149.850.84
+0.56%
Xylem
TMDX115.69-0.38
-0.33%
TransMedics Group
RAIL9.50-0.05
-0.52%
FreightCar America
MWYN1.12-0.02
-1.75%
Marwynn Holdings Inc.

LEXX and

Correlation & Price change

A.I.dvisor tells us that LEXX and PEPG have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LEXX and PEPG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEXX
1D Price
Change %
LEXX100%
-1.20%
PEPG - LEXX
29%
Poorly correlated
+0.98%
PDSB - LEXX
29%
Poorly correlated
N/A
MIST - LEXX
28%
Poorly correlated
-3.21%
BTAI - LEXX
27%
Poorly correlated
-4.17%
EPRX - LEXX
27%
Poorly correlated
-2.50%
More